Prior to joining Hatteras, Mike was a Vice President in Silicon Valley Bank’s Corporate Finance Group where he focused on emerging life science companies and venture capital funds. Prior to SVB, he held research scientist positions in the Department of Biochemistry at UNC-Chapel Hill, the Laboratory of Structural Biology at the National Institute of Environmental Health Sciences, and the UNC-Duke Michael Hooker Proteomics Center. He has performed research in the fields of cell cycle regulation, proteomics, and cancer therapy. Mike has published seven peer reviewed scientific articles and has presented at numerous international scientific conferences.
Mike serves on the board of Curoverse and is a board observer at Viamet Pharmaceuticals, Clinverse, and G1 Therapeutics. He holds a doctorate in biochemistry and biophysics from the University of North Carolina at Chapel Hill.
Community and Board Engagements:
Mike has served on various committees and panels for the North Carolina Biotech Center, Council for Entrepreneurial Development, SE BIO, PTP NEXT and Durham’s Partnership for Children.
Jeff joined the Hatteras team in January 2012 to work with Pathfinder, one of Hatteras’ portfolio companies, and also to assist with diligence on potential Hatteras investments. Prior to working with Hatteras, Jeff worked for Medtronic, in both their image-guided surgery and spinal implant divisions. Jeff held roles in clinical support, sales, and managed a territory for Medtronic Navigation. Prior to working with Medtronic, Jeff spent two years pursuing a career in professional football, spending time with two NFL teams.
Jeff is a board observer at NeuroTronik. He holds a bachelor’s degree from Princeton University, and an MBA from Duke University, with a focus on healthcare and finance.